Antipsychotic
734 results
1 - 100
Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia- Antipsychotic combinations for schizophrenia
- Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia
Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia - Antipsychotic medication for childhood‐onset schizophrenia
- Antipsychotic medications for cocaine dependence
- Antipsychotic medication for early episode schizophrenia
- Pharmacological treatment for antipsychotic‐related constipation
- Maintenance treatment with antipsychotic drugs for schizophrenia
- Benzodiazepines for antipsychotic‐induced tardive dyskinesia
Metformin effective for antipsychotic-induced amenorrhea- Antipsychotic medication for childhood-onset schizophrenia
- Increasing antipsychotic dose for non response in schizophrenia
- Anticholinergic medication for antipsychotic‐induced tardive dyskinesia
- Vitamin E for antipsychotic‐induced tardive dyskinesia
- Antipsychotic medication for elderly people with schizophrenia
- Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia
- Pharmacological treatment for antipsychotic-related constipation
- Chlorpromazine versus atypical antipsychotic drugs for schizophrenia
- Calcium channel blockers for antipsychotic‐induced tardive dyskinesia
- Management of sexual dysfunction due to antipsychotic drug therapy
- Cholinergic medication for antipsychotic‐induced tardive dyskinesia
- Antipsychotic medication for challenging behaviour in people with learning disability
- Psychosocial interventions for reducing antipsychotic medication in care home residents
- Maintenance treatment with antipsychotic drugs for schizophrenia
- Antipsychotic drugs for non‐affective psychosis during pregnancy and postpartum
- Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
- Gamma‐aminobutyric acid agonists for antipsychotic‐induced tardive dyskinesia
- Antipsychotic drug treatment for elderly people with late‐onset schizophrenia
- Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
- Antipsychotic medication versus placebo for people with both schizophrenia and learning disability
- Antipsychotic drugs more effective than mood stabilizers in acute mania
- Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
- Haloperidol versus first-generation antipsychotic drugs for schizophrenia
- Aripiprazole versus typical antipsychotic drugs for schizophrenia: Cochrane systematic review
- Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
- Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review
- No clear difference among antipsychotic agents in preventing relapse in adults with schizophrenia
- Risperidone versus typical antipsychotic medication for schizophrenia
- Risperidone versus other atypical antipsychotic medication for schizophrenia: Cochrane systematic review
- Chlorpromazine versus atypical antipsychotic drugs for schizophrenia
- Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review
- Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review
- Newer atypical antipsychotic medication versus clozapine for schizophrenia: Cochrane systematic review
- Clozapine combined with different antipsychotic drugs for treatment‐resistant schizophrenia
- Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia
- Antipsychotic use during pregnancy is not associated with lower school test scores in offspring
- Quetiapine versus typical antipsychotic medications for schizophrenia: Cochrane systematic review
- Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
- Gamma-aminobutyric-acid (GABA) agonists for antipsychotic-induced tardive dyskinesia (TD)
- No benefit to routine antipsychotic use for treatment or prevention of delirium in hospitalized patients
- Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review
- Withdrawal versus continuation of long‐term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia
- Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis
- Risperidone vs. other atypical antipsychotic medication for schizophrenia
- Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems
- Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia